- Home
- WH vs QGEN Comparison
WH vs QGEN Comparison
Compare WH & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WH
- QGEN
- Stock Information
- Founded
- WH 2017
- QGEN 1986
- Country
- WH United States
- QGEN Netherlands
- Employees
- WH N/A
- QGEN N/A
- Industry
- WH Hotels/Resorts
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WH Consumer Discretionary
- QGEN Health Care
- Exchange
- WH Nasdaq
- QGEN Nasdaq
- Market Cap
- WH 8.5B
- QGEN 9.9B
- IPO Year
- WH N/A
- QGEN 1996
- Fundamental
- Price
- WH $90.48
- QGEN $40.16
- Analyst Decision
- WH Strong Buy
- QGEN Buy
- Analyst Count
- WH 11
- QGEN 8
- Target Price
- WH $116.36
- QGEN $49.79
- AVG Volume (30 Days)
- WH 1.2M
- QGEN 1.1M
- Earning Date
- WH 04-23-2025
- QGEN 04-28-2025
- Dividend Yield
- WH 1.81%
- QGEN 3.31%
- EPS Growth
- WH 5.87
- QGEN N/A
- EPS
- WH 3.61
- QGEN 0.37
- Revenue
- WH $1,404,000,000.00
- QGEN $1,978,214,000.00
- Revenue This Year
- WH $9.83
- QGEN $5.15
- Revenue Next Year
- WH $7.33
- QGEN $6.49
- P/E Ratio
- WH $25.06
- QGEN $107.70
- Revenue Growth
- WH 1.45
- QGEN 0.66
- 52 Week Low
- WH $67.67
- QGEN $37.63
- 52 Week High
- WH $113.07
- QGEN $47.93
- Technical
- Relative Strength Index (RSI)
- WH 36.21
- QGEN 53.09
- Support Level
- WH $90.81
- QGEN $39.35
- Resistance Level
- WH $93.58
- QGEN $40.11
- Average True Range (ATR)
- WH 2.69
- QGEN 0.53
- MACD
- WH 0.22
- QGEN 0.20
- Stochastic Oscillator
- WH 54.07
- QGEN 92.43
About WH Wyndham Hotels & Resorts Inc.
As of Dec. 31, 2024, Wyndham Hotels & Resorts operates 903,000 rooms across more than 20 brands predominantly in the economy and midscale segments. Super 8 is the largest brand, representing around 18% of all rooms, with Days Inn (13%) and Ramada (14%) the next two largest brands. During the past several years, the company has expanded its extended stay/lifestyle brands, which appeal to travelers seeking to experience the local culture of a given location. The company closed its La Quinta acquisition in the second quarter of 2018, adding around 90,000 rooms at the time the deal closed. Wyndham launched a new extended stay economy scale segment concept, ECHO, in the spring of 2022. The United States represents 56% of total rooms.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).